pH imaging

IEEE Engineering in Medicine and Biology Magazine

Volumn 23, Issue 5, 2004, Pages 57-64

  Gillies, Robert J ^a,b,c,d   Raghunand, Natarajan ^d,e,f,g   Garcia Martin, Maria L ^d,h   Gatenby, Robert A ^i,j,k,l  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Dept of Biochem/Molec Biophys ^*  (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^f Department of Environmental and Radiological Health Sciences   (United States)

^g TEXAS A AND M UNIVERSITY   (United States)

^h Biomedical Research Foundation   (Spain)

ⁱ PRINCETON UNIVERSITY   (United States)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

^k HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^l UNIVERSITY OF ARIZONA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PATHOLOGY; PH IMAGING;

BLOOD; DRUG INFUSION; MAGNETIZATION; METABOLISM; PATHOLOGY; PH EFFECTS; TUMORS;

MEDICAL IMAGING;

ACETAZOLAMIDE; AMILORIDE; BAFILOMYCIN; CONCANAMYCIN A; CONTRAST MEDIUM; GADOLINIUM; GADOLINIUM DOTP; GADOTERIC ACID; OMEPRAZOLE; STILBENE; UNCLASSIFIED DRUG; FLUORINE; GD DOTA 4AMP; GD-DOTA-4AMP; ORGANOMETALLIC COMPOUND; PHOSPHORUS; SINGLE HETEROCYCLIC RINGS;

ACID BASE BALANCE; BLOOD PH; CANCER; CELL PH; CHEMICAL EXCHANGE SATURATION TRANSFER; CHEMICAL REACTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG INFUSION; HOMEOSTASIS; HUMAN; IMAGING SYSTEM; ISCHEMIA; KIDNEY FAILURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PH MEASUREMENT; REVIEW; ANIMAL; CHEMISTRY; METHODOLOGY; NEOPLASM; PH; PHYSIOLOGY;

ACID-BASE EQUILIBRIUM; ANIMALS; CONTRAST MEDIA; FLUORINE; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASMS; ORGANOMETALLIC COMPOUNDS; PHOSPHORUS ISOTOPES;

EID: 16644376266     PISSN: 07395175     EISSN: None     Source Type: Journal    
DOI: 10.1109/MEMB.2004.1360409     Document Type: Review

References (70)

1. A. Schurr, R.S. Payne, J.J. Miller, M.T. Tseng, and B.M. Rigor, "Blockade of lactate transport exacerbates delayed neuronal damage in a rat model of cerebral ischemia," Brain Res., vol. 895, no. 1-2, pp. 268-272, Mar. 2001.
2. C. Zhao, M.C. Wilson, F. Schuit, A.P. Halestrap, and G.A. Rutter, "Expression and distribution of lactate/monocarboxylate transporter isoforms in pancreatic islets and the exocrine pancreas," Diabetes, vol. 50, no. 2, pp. 361-366, Feb. 2001.
3. D. Eladari, R. Chambrey, T. Irinopoulou, F. Leviel, F. Pezy, P. Bruneval, M. Paillard, and R.A. Podevin, "Polarized expression of different monocarboxylate transporters in rat medullary thick limbs of Henle," J. Biol. Chem., vol. 274, no. 40, pp. 28420-28426, Oct. 1999.
4. + exchanger isoforms (NHE-1,-2, and -3) are differentially responsive to second messenger agonists of the protein kinase A and C pathways," J. Biol. Chem., vol. 270, no. 49, pp. 29209-29216, Dec. 1995.
5. + exchanger NHE-1," J. Biol. Chem., vol. 266, pp. 10,813-10,819, 1991.
6. + exchanger, NHE-1, by phosphorylating a set of common sites," J. Biol. Chem., vol. 266, pp. 19,166-19,171, Oct. 1991.
7. +ATPase from bovine kidney," J. Biol. Chem., vol. 262, pp. 15,780-15,789, May 1987.
8. +-ATPase regulates cytoplasmic pH in murine macrophages," J. Biol. Chem., vol. 265, pp. 7645-7654, May 1990.
9. R. Martinez-Zaguilan, R.M. Lynch, G.M. Martinez, and R.J. Gillies, "Vacuolar type proton ATPases are functionally expressed in the plasma membranes of human tumor cells," Am. J. Physiol., vol. 265, pp. c1015-c1029, Oct. 1993.
10. R.D. Vaughan-Jones and K.W. Spitzer, "Role of bicarbonate in the regulation of intracellular pH in the mammalian ventricular myocyte," Biochem. & Cell Biology, vol. 80, no. 5, pp. 579-596, 2002.
11. T.L. Pannabecker, O.K. Brokl, Y.K. Kim, D.E. Abbott, and W.H. Dantzler, "Regulation of intracellular pH in rat renal inner medullary thin limbs of Henle's loop," Pflugers Archiv-European J. Physiol., vol. 443, no. 3, pp. 446-457, Jan. 2002.
12. -3 cotransporter NBC," JOP. J. Pancreas, vol. 2, no. 4 (Suppl.), pp. 182-191, 2001.
13. H. Yamada, S. Yamazaki, N. Moriyama, C. Hara, S. Horita, Y. Enomoto, A. Kudo, H. Kawakami, Y. Tanaka, T. Fujita, and G. Seki, "Localization of NBC-1 variants in human kidney and renal cell carcinoma," Biochem. Biophys. Res. Comm., vol. 310, pp. 1213-1218, Oct. 2003.
14. M.L. Wahl, P.M. Pooler, P. Briand, D.B. Leeper, and C.S. Owen, "Intracellular pH regulation in a nonmalignant and a derived malignant human breast cell line," J. Cellular Physiol., vol. 183, no. 3, pp. 373-380, June 2000.
15. +-ATPase in drug-resistant human breast carcinoma cell lines," Biochem. Pharmacol., vol. 57, no. 9, pp. 1037-1046, May 1999.
16. 2+," Experimental Cell Res., vol. 242, no. 1, pp. 128-137, July 1998.
17. C. Remy, N. Fouilhe, I. Barba, E. Sam-Lai, H. Lahrech, M.G. Cucurella, M. Izquierdo, A. Moreno, A. Ziegler, R. Massarelli, M. Decorps, and C. Arus, "Evidence that mobile lipids detected in rat brain glioma by 1H nulear magnetic resonance correspond to lipid droplets," Cancer Res., vol. 57, no. 3, pp. 407-414, Feb. 1997.
18. Y. Perez, H. Lahrech, M.E. Cabanas, R. Barnadas, M. Sabes, C. Remy, and C. Arus, "Measurement by nuclear magnetic resonance diffusion of the dimensions of the mobile lipid compartment in C6 cells," Cancer Res., vol. 62, no. 20, pp. 5672-5677, Oct. 2002.
19. B. Binas, X.X. Han, E. Erol, J.J. Luiken, J.F. Glatz, D.J. Dyck, R. Motazavi, P.J. Adihetty, D.A. Hood, and A. Bonen, "A null mutation in H-FABP only partially inhibits skeletal muscle fatty acid metabolism," Amer. J. Physiol.-Endocrinology and Metabolism, vol. 285, no. 3, pp. E481-E489, Sept. 2003.
20. P. Besnard, I. Niot, H. Poirier, L. Clement, and A. Bernard, "New insights into the fatty acid-binding protein (FABP) family in the small intestine," Molecular and Cell. Biochem., vol. 239, no. 1-2, pp. 139-147, Oct. 2002.
21. M. Endo, R. Jain, B. Witwer, and D. Brown, "Water channel (Aquaporin 1) expression and distribution in mammary carcinomas and glioblastomas," Microvascular Res., vol. 58, pp. 89-98, Sept. 1999.
22. + transport in the interstitial fluid," in Novartis Foundation Symp., vol. 240, 2001, pp. 46-62.
23. + diffusion to the acidic pH of tumors," Neoplasia (New York), vol. 5, no. 2, pp. 135-145, 2003.
24. H.E. Adrogue and H.J. Adrogue, "Acid-base physiology," Respiratory Care, vol. 46, no. 4, pp. 328-341, Apr. 2001.
25. H.J. Adrogue and N.B. Madias, "Management of life-threatening acid-base disorders. First of two parts," New Eng. J. Med., vol. 338, no. 1, pp. 26-34, Jan. 1998.
26. H.J. Adrogue and N.B. Madias, "Management of life-threatening acid-base disorders. Second of two parts," New Eng. J. Med., vol. 338, no. 2, pp. 107-111, Jan. 1998.
27. M. Stubbs, Z.M. Bhujwalla, G.M. Tozer, L.M. Rodrigues, R.J. Maxwell, R. Morgan, F.A. Howe, and J.R. Griffiths, "An assessment of 31P MRS as a method of measuring pH in rat tumours," NMR Biomed., vol. 5, no. 6, pp. 351-359, Nov. 1992.
28. N. Raghunand, M.I. Altbach, R. van Sluis, B. Baggett, C.W. Taylor, Z.M. Bhujwalla, and R.J. Gillies, "Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy," Biochem. Pharmacology, vol. 57, no. 3, pp. 309-312, Feb. 1999.
29. E.R. Swenson, "Metabolic acidosis," Respiratory Care, vol. 46, no. 4, pp. 342-353, Apr. 2001.
30. N.A. Kurtzman, "Renal tubular acidosis syndromes," Southern Med. J., vol. 93, no. 11, pp. 1042-1052, Nov. 2000.
31. +-ATPases," Seminars Nephrology, vol. 19, no. 5, pp. 431-437, Sept. 1999.
32. P. Jarolim, C. Shayakul, D. Prabakaran, L. Jiang, A. Stuart-Tilley, H.L. Rubin, S. Simova, J. Zavadil, J.T. Herrin, J. Brouillette, M.J. Somers, E. Seemanova, C. Brugnara, L.M. Guay-Woodford, and S.L. Alper, "Autosomal dominant distal renal tubular acidosis is associated in three families with heterozygosity for the R589H mutation in the AE1 (band 3) Cl-/HCO3- exchanger," J. Biol. Chem., vol. 273, no. 11, pp. 6380-6388, Mar. 1998.
33. D.C. Battle, "Hyperkalemic hypercholoremic metabolic acidosis associated with selective aldosterone deficiency and distal renal tubular acidosis," Seminars Nephrol, vol. 1, pp. 260-273, 1981.
34. A.S. Ojugo, P.M. McSheehy, D.J. McIntyre, C. McCoy, M. Stubbs, M.O. Leach, I.R. Judson, and J.R. Griffiths, "Measurement of the extracellular pH of solid tumours in mice by magnetic resonance spectroscopy: A comparison of exogenous (19)F and (31)P probes," NMR Biomed., vol. 12, no. 8, pp. 495-504, Dec. 1999.
35. R.J. Gillies, Z. Liu, and Z. Bhujwalla, "31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate," Amer. J. Physiol., vol. 267, no. 1, pt. 1, pp. t-203, July 1994.
36. C. Deutsch, J.S. Taylor, and D.F. Wilson, "Regulation of intracellular pH by human peripheral blood lymphocytes as measured by 19-F NMR," in Proc. Nat. Academy of Sciences: USA, vol. 79, pp. 7944-7948, 1982.
37. C. Deutsch, J.S. Taylor, and M. Price, "pH Homeostatis in human lymphocytes: Modulation by ions and mitogen," J. Cell Biol., vol. 98, pp. 885-894, Mar. 1984.
38. J.S. Taylor, C. Deutsch, G.G. McDonald, and D.F. Wilson, "Measurement of Transmembrane pH gradients in human erythrocytes using 19F-NMR1," Analytical Biochem., vol. 114, no. 1, pp. 415-418, 1981.
39. J.S. Taylor and C. Deutsch, "Fluorinated alpha-methylamino acids as 19-F NMR indicators of intracellular pH," Biophys. J., vol. 43, pp. 261-267, Sept. 1983.
40. R.P. Mason, "Transmembrane pH gradients in vivo: Measurements using fluorinated vitamin B6 derivatives," Current Medicinal Chem., vol. 6, pp. 481-499, June 1999.
41. W. Cui, P.Y.J. Otten, V. Kodibagkar, and R.P. Mason, "6- trifluoromethyl pyridoxal, a novel reporter molecule for tumor extracellular pH," in Proc. Int. Soc. for Magnetic Resonance in Medicine, 2003, vol. 11, p. 623.
42. P.M. McSheehy, M.T. Seymour, A.S. Ojugo, L.M. Rodrigues, M.O. Leach, I.R. Judson, and J.R. Griffiths, "A pharmacokinetic and pharmacodynamic study in vivo of human HT29 tumours using 19F and 31P magnetic resonance spectroscopy," Eur. J. Cancer, vol. 33, no. 14, pp. 2418-2427, Dec. 1997.
43. 1H NMR probes for intracellular pH," Bioorganic and Med. Chem. Lett., vol. 2, no. 12, pp. 1717-1722, 1992.
44. 1H NMR probes for the determination of intracellular pH, extracellular pH and cell volume," Bioorganic and Med. Chem. Lett., vol. 2, no. 5, pp. 305-314, 1994.
45. R. van Sluis, Z.M. Bhujwalla, N. Raghunand, P. Ballesteros, J. Alvarez, S. Cerdan, J.P. Galons, and R.J. Gillies, "In vivo imaging of extracellular pH using 1H MRSI," Magnetic Resonance in Med., vol. 41, no. 4, pp. 743-750, Apr. 1999.
46. Z.M. Bhujwalla, D. Artemov, P. Ballesteros, S. Cerdan, R.J. Gillies, and M. Solaiyappan, "Combined vascular and extracellular pH imaging of solid tumors," NMR Biomed., vol. 15, no. 2, pp. 114-119, Apr. 2002.
47. M.L. Garcia-Martin, G. Herigault, C. Remy, R. Farion, P. Ballesteros, J.A. Coles, S. Cerdan, and A. Ziegler, "Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: Comparison with maps of metabolites," Cancer Res., vol. 61, no. 17, pp. 6524-6531, Sept. 2001.
48. 1H MRS detection of histidine in human brain: Application to in vivo pH measurement," Magnetic Resonance Med., vol. 43, no. 5, pp. 665-675, May 2000.
49. K.M. Ward and R.S. Balaban, "Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST)," Magnetic Resonance Med., vol. 44, no. 5, pp. 799-802, Nov. 2000.
50. R.M. Henkelman, G.J. Stanisz, and S.J. Graham, "Magnetization transfer in MRI: A review," NMR in Biomed., vol. 14, no. 2, pp. 57-64, Apr. 2001.
51. E. Liepinsh and G. Otting, "Proton exchange rates from amino acid side chains-implications for image contrast," Magnetic Resonance Med., vol. 35, no. 1, pp. 30-42, Jan. 1996.
52. P.C. van Zijl, J. Zhou, N. Mori, J.F. Payen, D. Wilson, and S. Mori, "Mechanism of magnetization transfer during on-resonance water saturation. A new approach to detect mobile proteins, peptides, and lipids," Magnetic Resonance Med., vol. 49, no. 3, pp. 440-449, Mar. 2003.
53. 1," Radiology, vol. 192, pp. 521-529, Aug. 1994.
54. S. Forsen and R. Hoffman, "Study of moderately rapid chemical exchange reactions by means of nuclear magnetic double resonance," J. Chem. Phys., vol. 39, pp. 2892-2901, 1963.
55. D. Leibfritz and W. Dreher, "Magnetization transfer MRS," NMR Biomed., vol. 14, no. 2, pp. 65-76, Apr. 2001.
56. S.D. Wolff and R.S. Balaban, "Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo," Magnetic Resonance Med., vol. 10, pp. 135-144, Apr. 1989.
57. J. Zhou, J.F. Payen, D.A. Wilson, R.J. Traystman, and P.C. van Zijl, "Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI," Nature Med., vol. 9, no. 8, pp. 1085-1090, Aug. 2003.
58. S. Mori, S.M. Eleff, U. Pilatus, N. Mori, and P.C. van Zijl, "Proton NMR spectroscopy of solvent-saturable resonances: A new approach to study pH effects in situ," Magnetic Resonance Med., vol. 40, no. 1, pp. 36-42, July 1998.
59. J. Zhou, B. Lal, D. Wilson, J. Laterta, and P.C. van Zijl, "Amide proton transfer (APT) contrast for imaging of brain tumors," Magnetic Resonance Med., vol. 50, pp. 1120-1126, Dec. 2003.
60. P.C. van Zijl, N. Goffeney, J. Duyn, L.H. Bryant, and J. Bulte, "The use of starburst dendrimers as pH contrast agents," in Proc. Int. Soc. Magnetic Resonance in Med., 2003, vol. 9, p. 878.
61. S. Aime, A. Barge, C.D. Delli, F. Fedeli, A. Mortillaro, F.U. Nielsen, and E. Terreno, "Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications," Magnetic Resonance Med., vol. 47, no. 4, pp. 639-648, Apr. 2002.
62. S. Zhang, P. Winter, L. Wu, and A.D. Sherry, "A novel Europium(III)-based MRI contrast agent," J. Amer. Chem. Soc., vol. 123, pp. 1517-1518, Feb. 2001.
63. S. Zhang, K. Wu, and A.D. Sherry, "A novel pH-sensitive MRI contrast agent," Angewandte Chemie Int. Ed., vol. 38, pp. 3192-3194, Dec. 1999.
64. S. Aime, M. Botta, S.G. Crich, G. Giovenzana, G. Palmisano, and M. Sisti, "Novel paramagnetic macromolecular complexes derived from the linkage of a macrocyclic Gd(III) complex to polyamino acids through a squaric acid moiety," Biocon. Chem., vol. 10, no. 2, pp. 192-199, Mar.-Apr. 1999.
65. 3+ loaded polyion complex for pH depiction with magnetic resonance imaging," J. Biomed. Mat. Res., vol. 49, pp. 390-395, Mar. 2000.
66. D.A. Beauregard, D. Parker, and K.M. Brindle, "Relaxation-based mapping of tumor pH," in Proc. Int. Soc. for Magnetic Resonance in Med., 1998, vol. 6, p. 53.
67. N. Raghunand, C. Howison, A.D. Sherry, S. Zhang, and R.J. Gillies, "Renal and systemic pH imaging by contrast-enhanced MRI," Magnetic Resonance Med., vol. 49, no. 2, pp. 249-257, Feb. 2003.
68. N. Raghunand, S. Zhang, A.D. Sherry, and R.J. Gillies, "In vivo magnetic resonance imaging of tissue pH using a novel pH-sensitive contrast agent, GdDOTA-4AmP," Academic Radiology, vol. 9, supp. 2, pp. S481-S483, Aug. 2002.
69. R.J. Gillies, N. Raghunand, G.S. Karczmar, and Z.M. Bhujwalla, "MRI of the tumor microenvironment," J. Magnetic Resonance Imaging, vol. 16, no. 4, pp. 430-450, Oct. 2002.
70. 2+ using the fluorescence of SNARF-1 and Fura-2," Amer. J. Physiol., vol. 260, pp. C297-C307, Feb. 1991.